This statistical report, co-authored with the UK Health Security Agency (UKSHA), reports childhood vaccination coverage statistics for England in 2022-23. Data relates to the routine vaccinations offered to all children up to the age of 5 years, derived from the Cover of Vaccination Evaluated Rapidly (COVER). Additional information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through UKHSA's ImmForm system.

Coronavirus (COVID-19) vaccination rates among adults who live in England, including estimates by socio-demographic characteristic and Standard Occupational Classification (SOC) 2020

As of July 17, 2022, it was estimated that around every person aged 75 to 79 years of age in England had received at least two doses of a COVID-19 vaccine. Although the source does mention that this is likely to be an overestimation due to population figures taken from 2020. The data shows that at least a quarter of men under 30 years of age have not yet had two vaccine doses, with women more likely to be vaccinated among younger age groups.

As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.

The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

This statistic displays the share of children who received a first dose and a second dose of Measles, Mumps and Rubella (MMR) immunization in England, from 2003/04 to 2023/24. In the year 2023/24, 83.9 percent of children had received their MMR immunization by their fifth birthday.

Vaccination rates and odds ratios by socio-demographic group among people living in England.

View daily updates and historical trends for UK Coronavirus Full Vaccination Rate. from United Kingdom. Source: Our World in Data. Track economic data wit…

As of July 13, 2022, approximately 53.7 million people in the United Kingdom had received the first dose of the COVID-19 vaccination. The UK was the first country in the world to approve the use of the Pfizer/BioNTech vaccine, and began inoculations on December 8, 2020. Nearly all the vaccines currently being used in the UK require two doses for full efficacy to occur, and according to the latest data around 50.3 million people had received their second dose of the immunization. Furthermore, 40.1 million booster vaccinations had been administered.

The total number of cases in the UK can be found here. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

The MMR vaccine in the United Kingdom is a combined vaccine which immunizes against measles, mumps and rubella. In 2023/24, 85.6 percent of children in Scotland had received the second dose of the vaccine by their fifth birthday, compared to 83.9 percent of children in England. Rise of measles in recent years In 2018, there were 989 cases of measles in England and Wales, this was the highest number of annual recorded cases since 2013. From 2000 to 2019, cases of measles generally increased in England and Wales. Views towards vaccines in the UK In the UK most of the population believe in the safety and effectiveness of vaccines. A 2018 survey of British respondents showed that 89 percent of the population believed that vaccines are important for children to have. In the same survey question, sixteen other European countries had a higher belief in the importance of child vaccinations than the UK, compared to twenty-one other countries which scored lower than the UK.

This statistical report, co-authored with Public Health England (PHE), reports childhood vaccination coverage statistics for England in 2018-19. Data relates to the routine vaccinations offered to all children up to the age of five years, derived from the Cover of Vaccination Evaluated Rapidly (COVER). Additional information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through PHE's ImmForm system.

Forecast: Measles Vaccination Rates Among Children in the UK 2022 - 2026 Discover more data with ReportLinker!

Vaccinations in London Between 8 December 2020 and 15 September 2021 5,838,305 1st doses and 5,232,885 2nd doses have been administered to London residents. Differences in vaccine roll out between London and the Rest of England London Rest of England Priority Group Vaccinations given Percentage vaccinated Vaccinations given Percentage vaccinated Group 1 Older Adult Care Home Residents 21,883 95% 275,964 96% Older Adult Care Home Staff 29,405 85% 381,637 88% Group 2 80+ years 251,021 83% 2,368,284 93% Health Care Worker 174,944 99% 1,139,243 100%* Group 3 75 - 79 years 177,665 90% 1,796,408 99% Group 4 70 - 74 years 252,609 90% 2,454,381 97% Clinically Extremely Vulnerable 278,967 88% 1,850,485 95% Group 5 65 - 69 years 285,768 90% 2,381,250 97% Group 6 At Risk or Carer (Under 65) 983,379 78% 6,093,082 88% Younger Adult Care Home Residents 3,822 92% 30,321 93% Group 7 60 - 64 years 373,327 92% 2,748,412 98% Group 8 55 - 59 years 465,276 91% 3,152,412 97% Group 9 50 - 54 years 510,132 90% 3,141,219 95% Data as at 15 September 2021 for age based groups and as at 12 September 2021 for non-age based groups * The number who have received their first dose exceeds the latest official estimate of the population for this group There is considerable uncertainty in the population denominators used to calculate the percentage vaccinated. Comparing implied vaccination rates for multiple sources of denominators provides some indication of uncertainty in the true values. Confidence is higher where the results from multiple sources agree more closely. Because the denominator sources are not fully independent of one another, users should interpret the range of values across sources as indicating the minimum range of uncertainty in the true value. The following datasets can be used to estimate vaccine uptake by age group for London: ONS 2020 mid-year estimates (MYE). This is the population estimate used for age groups throughout the rest of the analysis. Number of people ages 18 and over on the National Immunisation Management Service (NIMS) ONS Public Health Data Asset (PHDA) dataset. This is a linked dataset combining the 2011 Census, the General Practice Extraction Service (GPES) data for pandemic planning and research and the Hospital Episode Statistics (HES). This data covers a subset of the population. Vaccine roll out in London by Ethnic Group Understanding how vaccine uptake varies across different ethnic groups in London is complicated by two issues: Ethnicity information for recipients is unavailable for a very large number of the vaccinations that have been delivered. As a result, estimates of vaccine uptake by ethnic group are highly sensitive to the assumptions about and treatment of the Unknown group in calculations of rates. For vaccinations given to people aged 50 and over in London nearly 10% do not have ethnicity information available, The accuracy of available population denominators by ethnic group is limited. Because ethnicity information is not captured in official estimates of births, deaths, and migration, the available population denominators typically rely on projecting forward patterns captured in the 2011 Census. Subsequent changes to these patterns, particularly with respect to international migration, leads to increasing uncertainty in the accuracy of denominators sources as we move further away from 2011. Comparing estimated population sizes and implied vaccination rates for multiple sources of denominators provides some indication of uncertainty in the true values. Confidence is higher where the results from multiple sources agree more closely. Because the denominator sources are not fully independent of one another, users should interpret the range of values across sources as indicating the minimum range of uncertainty in the true value. The following population estimates are available by Ethnic group for London:

Forecast: Diphtheria, Tetanus and Pertussis Vaccination Rates Among Children in the UK 2022 - 2026 Discover more data with ReportLinker!

Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

Forecast: Total Influenza Vaccination Rates in the UK 2022 - 2026 Discover more data with ReportLinker!

Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the Code of Practice for Statistics that all producers of official statistics should adhere to.

Provisional monthly uptake data for seasonal influenza and COVID-19 vaccines for frontline HCWs working in trusts, Independent Sector Healthcare Providers (ISHCPs), and GP practices in England.

Data is presented at national, NHS regional and individual trust levels.

View the pre-release access list for these reports.

All children for whom the local authority is responsible who received two doses of MMR on or after their first birthday and at any time up to their fifth birthday as a percentage of all children whose fifth birthday falls within the time period.RationaleMMR is the combined vaccine that protects against measles, mumps and rubella. Measles, mumps and rubella are highly infectious, common conditions that can have serious complications, including meningitis, swelling of the brain (encephalitis) and deafness. They can also lead to complications in pregnancy that affect the unborn baby and can lead to miscarriage.Vaccination coverage is the best indicator of the level of protection a population will have against vaccine preventable communicable diseases. Coverage is closely correlated with levels of disease. Monitoring coverage identifies possible drops in immunity before levels of disease rise.The first MMR vaccine is given to children as part of the routine vaccination schedule, usually within a month of their first birthday. They'll then have a booster dose before starting school, which is usually between three and five years of age. Previous evidence shows that highlighting vaccination programmes encourages improvements in uptake levels.May also have relevance for NICE guidance PH21: Reducing differences in the uptake of immunisations (The guidance aims to increase immunisation uptake among those aged under 19 years from groups where uptake is low).Definition of numeratorTotal number of children whose fifth birthday falls within the time period who received two doses of MMR on or after their first birthday and at any time before their fifth birthday.Data for 2013 to 2014 are available at source at LA level. Data prior to 2013 to 2014 were collected at PCT level and converted to LA level using the criteria as described in the notes section below.Definition of denominatorTotal number of children whose fifth birthday falls within the time period.Data from 2013 and 2014 are available at source at LA level. Data prior to 2013 and 2014 were collected at PCT level and converted to LA level using the criteria as described in the notes section below.CaveatsFull GP postcodes are used to aggregate data to ICB. The GP-level coverage data is collected by NHS Digital Strategic Data Collection Service (SDCS) and published by the UK Health Security Agency (UKHSA) COVER team. ICB data is experimental data and should be treated with caution. It is not an official statistic.

In 2022, the immunisation of measles in the United Kingdom remained nearly unchanged at around **** percent of children aged less than one year. Still, 2022 marked the second consecutive decline of the immunisation in this industry. Find more key insights for the immunisation in countries like Denmark, Norway, and Sweden.